Neochem Bio Solutions Ltd (NEOCHEM) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Neochem Bio Solutions Ltd on NSE and BSE, with an AI summary of each filing.
Neochem Bio Solutions Limited has informed the Exchange about Transcript
Transcript · 03 Nov 2026, 12:06 am
Neochem Bio Solutions Delivers Strong H1 FY27 Performance with 50% Top-Line Growth Neochem reported a 50.4% YoY increase in H1 FY27 revenue from operations to Rs 68.9 Cr, with PAT rising 41.8% YoY to Rs 7.8 Cr (11.4% margin). Volume growth stood at 20% YoY, alongside an annual run-rate capacity utilization of 62%. Receivable days improved to 127 days from 161 days in Mar'26. Operating cash flows normalized significantly to negative Rs 1 Cr versus negative Rs 17 Cr in FY26. Management targets >40% CAGR over the next 5–6 years, with long-term EBITDA and PAT margin bands guided at 18%–20% and 10%–12%, respectively.
Neochem Bio Solutions Limited has informed the Exchange about Link of Recording
Audio / Video · 30 Oct 2026, 2:56 am
Neochem Bio Solutions Releases Audio Recording of Investor and Analyst Conference Call Neochem Bio Solutions Limited informed the National Stock Exchange of India that the audio recording of its Investors/Analysts Conference Call, held on 29th Oct'26 from 14:00 to 14:45 IST, is accessible on the company's official website pursuant to Regulation 30 and 46 of SEBI LODR Regulations.
Neochem Bio Solutions Limited has informed the Exchange about Investor Presentation
Investor Presentation · 29 Oct 2026, 5:52 pm
Neochem Bio Solutions Reports Strong H1 FY27 Results Driven by Specialty Chemical Expansion Neochem Bio Solutions reported a 50% YoY increase in revenue from operations to INR 68.9 crore for H1 FY27, with EBITDA rising 25% YoY to INR 12.4 crore (18.0% margin) and PAT growing 43% YoY to INR 7.8 crore (11.3% margin). Capacity utilization reached 61.8% at its 22,000 MTPA facility. Cash conversion cycle improved to 212 days from 246 days in FY26, while net debt-to-equity stood at 0.38x. Non-textile diversification advanced, with Home & Personal Care revenue expanding 35% YoY to INR 9.8 crore.
Neochem Bio Solutions Limited has submitted to the Exchange, the Unaudited Half Yearly financial results for the period ended September 30, 2026.
Outcome · 28 Oct 2026, 12:23 am
Neochem Bio Solutions Reports Strong H1 FY27 Results and Leadership Appointments For the half-year ended 30th Sep'26, Neochem Bio Solutions posted revenue from operations of ₹6,892.43 Lakhs, up 50.39% YoY from ₹4,583.16 Lakhs. Net profit rose 43.09% YoY to ₹784.69 Lakhs versus ₹548.38 Lakhs, with basic EPS reaching ₹4.58. Profit before tax stood at ₹1,045.59 Lakhs against ₹732.83 Lakhs in H1 FY26. Additionally, the board approved the appointment of CA Harshit Shah as Chief Financial Officer and Mr. Vikram Nair as Chief Commercial Officer, effective 27th Oct'26, while former CFO Mr. Pradip Solanki transitioned to Senior Management.
Neochem Bio Solutions Limited has informed the Exchange about Schedule of meet
Intimation · 27 Oct 2026, 12:13 am
Neochem Bio Solutions Schedules H1 FY27 Earnings Conference Call Neochem Bio Solutions Limited will host an earnings conference call for analysts and investors on 29th Oct'26 at 2:00 PM IST to discuss its standalone unaudited financial results for the half year ended 30th Sep'26. The financial results will be reviewed and approved at the Board of Directors meeting scheduled for 27th Oct'26. The call will feature key management, including Managing Director Swapnil Makati, Associate Director of Business Operations Shamik Nagar, and Chief Financial Officer Pradip Solanki.
NEOCHEM BIO SOLUTIONS LIMITED has informed the Exchange about Board Meeting to be held on 27-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 27 Oct 2026, 5:30 am
Neochem Bio Solutions Schedules Board Meeting for Half-Yearly Results Neochem Bio Solutions Ltd has notified the exchange that its Board of Directors will meet on 27th Oct'26. The primary agenda is to consider and approve the company's unaudited financial results for the half-year ended Sep'26.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 27 Oct 2026, 5:30 am
Neochem Bio Solutions Schedules Board Meeting for Half-Year Financial Results Neochem Bio Solutions Limited has scheduled a meeting of its Board of Directors on 27th Oct'26 to consider and approve the unaudited financial results for the half-year ended 30th Sep'26, alongside the statutory auditor's Limited Review Report. Additionally, in compliance with insider trading regulations, the trading window for dealing in company securities remains closed for all designated persons and their immediate relatives until 48 hours following the formal declaration of the financial results.
Neochem Bio Solutions has submitted Statement of Investor Grievances under Reg. 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended 30th September, 2026.
Others (Uncategorized) · 20 Oct 2026, 10:55 pm
Neochem Bio Solutions Reports Zero Investor Complaints for Quarter Ended Sep'26 Neochem Bio Solutions Limited reported zero investor complaints for the quarter and half-year ended 30th Sep'26 under Regulation 13(3) of SEBI LODR Regulations. According to the report from registrar MUFG Intime India, the company started the quarter with nil pending complaints, received zero complaints during the period across SEBI, BSE, NSE, physical letters, and emails, and concluded the quarter with no unresolved grievances.
Neochem Bio Solutions Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Quarter and half year ended on 30th September, 2026
Others (Uncategorized) · 20 Oct 2026, 7:04 pm
Neochem Bio Solutions Clarifies Corporate Governance and Related Party Transaction Compliance Neochem Bio Solutions Limited confirmed that quarterly corporate governance reporting under Regulation 27(2) of SEBI LODR is not applicable for the quarter and half year ended 30th Sep'26, as the company is listed on NSE's EMERGE SME platform. However, Regulation 23 regarding Related Party Transactions has become applicable because paid-up equity capital exceeded ₹10 crore and net worth surpassed ₹25 crore as of 31st Mar'26. The company maintains an approved RPT policy and Audit Committee to ensure compliance.
SDD Certificate as per SEBI (Prohibition of Insider Trading) Regulations, 2015
Others (Uncategorized) · 20 Oct 2026, 5:36 pm
Neochem Bio Solutions Submits SDD Compliance Certificate for Q2 and H1 FY27 Neochem Bio Solutions Limited submitted its Structured Digital Database (SDD) compliance certificate under Regulations 3(5) and 3(6) of SEBI (PIT) Regulations, 2015, for the quarter and half-year ended 30th Sep'26. Certified by practicing company secretary M. K. Chokshi & Associates on 19th Oct'26, the company confirmed full compliance with all SDD requirements. Neochem successfully captured all 7 required UPSI-related events during the quarter with internal audit trails maintained, reporting zero non-compliance issues.
Neochem Bio Solutions Limited has informed the Exchange about Presentation
Intimation · 23 Sept 2026, 9:05 pm
Neochem Bio Solutions Delivers Strong FY26 Growth With Expanding Margins Neochem Bio Solutions reported FY26 revenue from operations of ₹110.7 crore, up 32% YoY (35% 2-year CAGR), driven by domestic strength and expanding end-market applications. EBITDA surged 53% YoY to ₹22.6 crore with margins expanding 321 bps YoY to 20.4%, while PAT jumped 62% YoY to ₹12.0 crore. Capacity utilization at its 22,000 MTPA Ahmedabad plant rose to 52.7% from 41.8% in FY25. The company deleveraged significantly, reducing its net debt-to-equity ratio to 0.2x following its ₹42.7 crore IPO on NSE SME.
Neochem Bio Solutions Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 21, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 23 Sept 2026, 12:13 am
Neochem Bio Solutions Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 21, 2026
Annual General Meeting · 21 Sept 2026, 11:12 pm
Neochem Bio Solutions Limited has informed the Exchange about Schedule of meet
Intimation · 21 Sept 2026, 8:42 pm
Neochem Bio Solutions to Attend Arihant Capital Bharat Connect Virtual Conference Neochem Bio Solutions Limited announced management participation in Arihant Capital's Bharat Connect Virtual Conference Rising Star 2026. The virtual group meeting is scheduled for 25th Sep'26 at 02:00 PM. Discussions with investors and analysts will be restricted to publicly available information, with no unpublished price-sensitive information being shared.
Neochem Bio Solutions Limited has informed the Exchange regarding 'Neochem Bio Solutions Limited has informed the Exchange regarding Disclosure under Regulation 7(2) of SEBI (PIT) Regulations, 2015, for purchase of 1200 shares by Swapnil R. Makati, Managing Director of the Company'.
Others (Uncategorized) · 19 Sept 2026, 8:24 pm
Neochem Bio Solutions Promoter Acquires Additional Equity Stake via Open Market Promoter Swapnil Rameshbhai Makati acquired 1,200 equity shares (0.007% stake) of Neochem Bio Solutions Limited for a total consideration of Rs 13,50,000 on 18th Sep'26. The transaction was executed on the open market via the NSE. Following this purchase, the promoter's shareholding increased from 93,72,875 shares (54.74%) to 93,74,075 shares (54.75%). The company disclosed the acquisition under SEBI PIT Regulations on 19th Sep'26. No derivative transactions were reported.
Neochem Bio Solutions Limited has informed the Exchange regarding Disclosure under Regulation 7(2) of SEBI (PIT) Regulations, 2015, for purchase of 7200 shares by Swapnil R. Makati, Managing Director of the Company.
Others (Uncategorized) · 10 Sept 2026, 6:11 pm
Neochem Bio Solutions Promoter Swapnil Makati Acquires 0.042% Stake Via Market Purchase Neochem Bio Solutions Limited disclosed that promoter Swapnil Rameshbhai Makati acquired 7,200 equity shares (0.042% stake) via an on-market transaction on NSE on 9th Sep'26 for a total value of ₹7,44,600. Following this acquisition, the promoter's shareholding in the company increased from 93,65,675 equity shares (54.70%) to 93,72,875 equity shares (54.74%). The formal disclosure under SEBI PIT Regulations was submitted to the exchange on 10th Sep'26.
Neochem Bio Solutions Limited has informed the Exchange about change in Management regarding appointment of Mr. Siddharth Raj as Business Head - (Textiles) Corporate Accounts, Senior Management Personnel
Change in Management · 29 Aug 2026, 10:09 pm
Neochem Appoints Industry Veteran to Head Textiles Corporate Accounts Neochem Bio Solutions has appointed Mr. Siddharth Raj as Business Head (Textiles) Corporate Accounts, effective 29 Aug'26. A seasoned professional with over 20 years of experience in the textile dyes and chemicals industry, he will be part of the Senior Management. Mr. Raj previously held senior roles at Archroma International and Huntsman International. He holds a B.Tech in Textile Chemistry. This strategic appointment aims to leverage his extensive business development, segment leadership, and international operations experience to drive growth in the textiles vertical.
Neochem Bio Solutions Limited has informed the Exchange about about Dispatch Of Letter With Web-Link Of Annual Report For Financial Year 2025-26 to the Shareholders whose e-mail addresses are not registered with the Company.
Annual Report · 27 Aug 2026, 1:30 am
Neochem Bio Solutions Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 21, 2026 at 4:00 P.M.
Annual General Meeting · 27 Aug 2026, 12:47 am
Neochem Bio Solutions Limited has informed the Exchange regarding Outcome of Board Meeting held on August 24, 2026.
Outcome · 24 Aug 2026, 11:47 pm
Neochem Bio Sets 9th Annual General Meeting for Sep 21 Neochem Bio Solutions' Board of Directors, in its meeting on 24th Aug'26, approved the notice for its 9th Annual General Meeting (AGM) and the Board's Report for FY26. The AGM is scheduled for 21st Sep'26 at 4:00 PM IST and will be conducted virtually. The company will circulate the AGM notice and the FY26 annual report to its members and the exchange in due course.
Neochem Bio Solutions Limited has informed the Exchange about Resignation of Mr. Hitesh Wadher, Vice President - Marketing, Senior Management Personnel.
Change in Management · 21 Aug 2026, 11:09 pm
Neochem VP Marketing Resigns to Pursue Better Opportunities Neochem Bio Solutions (NSE: NEOCHEM) announced the resignation of Mr. Hitesh Wadher, Vice President - Marketing, a designated Senior Management Personnel (SMP). He tendered his resignation on 21st Aug'26 to pursue better career opportunities. The company has accepted his resignation, with his last day effective 31st Aug'26. The company stated there is no other material reason for the departure. Mr. Wadher served at the company for nearly four years and will ensure a smooth handover of responsibilities.
NEOCHEM BIO SOLUTIONS LIMITED has informed the Exchange about Board Meeting to be held on 24-Aug-2026 to consider Other business.
Intimation · 20 Aug 2026, 12:47 am
Neochem Bio Solutions Schedules Board Meeting for Other Business Neochem Bio Solutions has announced a Board of Directors meeting scheduled for 24-Aug-26. The agenda for the meeting is to consider unspecified "Other business." No further details regarding the specific matters to be discussed have been provided at this time.
To decide the day and date of 9th Annual General Meeting of the Company for the financial year ended 2025-26.
Intimation · 20 Aug 2026, 12:47 am
Neochem Bio Solutions has informed Exchange about SDD compliance certificate under Regulation 3(5) and 3(6) of SEBI (PIT) Regulations, 2015 for the quarter ended 30th June, 2026.
Others (Uncategorized) · 30 Jul 2026, 8:59 pm
Neochem Bio Solutions Submits Insider Trading Compliance Certificate for Q1FY27 Neochem Bio Solutions has filed its Structured Digital Database (SDD) compliance certificate for the quarter ended 30 Jun'26, as required by SEBI's Prohibition of Insider Trading regulations. The certificate, issued by a Practicing Company Secretary, confirms the company maintains a non-tamperable, internally managed database with access controls and an audit trail. It also verified that two required UPSI events during the quarter were successfully captured. No non-compliances were reported for the period.
Neochem Bio Solutions Limited has informed the Exchange regarding 'Neochem Bio Solutions Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of SEBI (PIT) Regulations, 2015, for purchase of 6000 shares by Swapnil R. Makati, Managing Director of the Company''.
Others (Uncategorized) · 28 Jul 2026, 11:03 pm
Neochem Promoter Acquires Additional Shares via Open Market Purchase Promoter Swapnil Rameshbhai Makati purchased 6,000 equity shares (0.035% of total) of Neochem Bio Solutions through an on-market transaction on 28th Jul'26. The total value of the purchase was ₹544,560. Following the acquisition, the promoter's shareholding increased from 93,59,675 shares (54.67%) to 93,65,675 shares (54.70%). This disclosure was made under SEBI's Prohibition of Insider Trading (PIT) Regulations, 2015.